Deep Medicine Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMAQ research report →
Price Chart
About the company
Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies.
- CEO
- Humphrey P. Polanen
- IPO
- 2021
- Employees
- 2
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on DMAQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $12.90M
- P/E
- -0.03
- PEG
- 0.00
- P/S
- 0.03
- P/B
- 0.56
- EV/EBITDA
- 0.22
- Div Yield
- 0.00%
- Gross Margin
- 50.49%
- Op Margin
- -22.58%
- Net Margin
- -55.68%
- ROE
- -294.36%
- ROIC
- -63.85%
Latest fiscal year · YoY change
- Revenue
- $18.88M-13.6%
- Gross Profit
- $9.52M-34.7%
- Op Income
- $-6,102,354
- Net Income
- $-15,227,893-73.1%
- EPS
- $-51.39+93.2%
- OCF Growth
- +57.5%
- FCF Growth
- +52.8%
- 52W High
- $19.91
- 52W Low
- $2.96
- 50D MA
- $10.77
- 200D MA
- $11.23
- Beta
- 0.02
- RSI (14)
- 15
- Avg Volume
- 14.21K
No earnings-call transcripts are available for DMAQ yet.
- Free Float
- 11.5%
- Shares Outstanding
- 4.36M
- Float Shares
- 501.86K
of shares held by institutions
13 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Cowen And Company, LLC | 40.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 31, 23 | Bright Vision Sponsor LLC | other | 150,000 |
| Oct 15, 22 | Chiang John | other | 0 |
| Oct 15, 22 | Chiang John | other | 0 |
| Oct 26, 21 | POLANEN HUMPHREY P | other | 0 |
| Oct 29, 21 | Bright Vision Sponsor LLC | other | 406,500 |
| Oct 26, 21 | LUO WEIXUAN | other | 0 |
| Oct 26, 21 | Miao Wanlei | other | 0 |
| Oct 26, 21 | Spires Tina | other | 0 |
| Oct 26, 21 | Bright Vision Sponsor LLC | other | 3,162,500 |
| Oct 26, 21 | Razmi Ronald M. | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DMAQ coverage
Recent articles, reports, and earnings notes.
No research on DMAQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMAQ report →TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP.
globenewswire.com · Jan 31
TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP.
globenewswire.com · Jan 12
Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.
globenewswire.com · Aug 2
Why Is Deep Medicine Acquisition (DMAQ) Stock Up 17% Today?
investorplace.com · Jul 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.